Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756665 · ClinicalTrials.gov registry record
Prostate Active Surveillance Study
A clinical trial of Prostatic Neoplasms, sponsored by University of Washington.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 11
- Study locations
NCT00756665: Recruiting study of Prostatic Neoplasms, sponsored by University of Washington.
NCT00756665 is a study of Prostatic Neoplasms that is actively recruiting participants, run by University of Washington. The registered enrollment target is 3,000 participants, above the 468-participant average among 65 other Prostatic Neoplasms trials with a reported enrollment target (541% higher). The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00756665, a study of Prostatic Neoplasms, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 11
- Study locations
Study Summary
The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.
Conditions Studied
Study Locations (11)
California
- Veterans Affairs San Francisco Health Care System - San Francisco
- University of California, San Francisco - San Francisco
- Stanford University - Stanford
Washington
- Veterans Affairs Puget Sound Health Care System - Seattle
- University of Washington - Seattle
Georgia
- Emory University - Atlanta
Massachusetts
- Beth Israel Deaconess Medical Center/Harvard Medical School - Boston
Michigan
- University of Michigan - Ann Arbor
Texas
- University of Texas Health Science Center, San Antonio - San Antonio
Virginia
- Eastern Virginia Medical School - Norfolk
British Columbia
- University of British Columbia - Vancouver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2008-07 |
| Est. Completion | 2032-09 |
What NCT00756665 shows while recruiting
NCT00756665 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 468-participant average among 65 other Prostatic Neoplasms trials with a reported enrollment target (541% higher).
The record links to 1 condition, with Prostatic Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT00756665 lists 11 locations in 8 states (California, Washington, Georgia).
Frequently Asked Questions
What is clinical trial NCT00756665 about?
NCT00756665 is a clinical study titled "Prostate Active Surveillance Study". The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This s...
What is the current status of trial NCT00756665?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2008-07. Estimated completion is 2032-09.
What conditions does trial NCT00756665 study?
This clinical trial studies the following conditions: Prostatic Neoplasms.
Who is sponsoring clinical trial NCT00756665?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00756665 being conducted?
This trial has 11 study locations across California, Georgia, Massachusetts, Michigan, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostatic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00756665's enrollment target sits among peer trials
3,000 1st of 65 higher than 65 of 65 other Prostatic Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostatic Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
RECRUITING · Phase 1
-
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
RECRUITING · NA
-
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
RECRUITING · Phase 1
-
A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
RECRUITING
-
Men at High Genetic Risk for Prostate Cancer
RECRUITING
-
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia